Introduction
Depression is the most common chronic condition next to hypertension experience in general medical practice. Out of ten patients visiting psychiatric outpatient department; one patient is suffering from major depression. Major Depressive Disorder (MDD) is defined by depressed mood or loss of interest in nearly all activities or both for at least two weeks, accompanied by a minimum of three or four of the following symptoms (for a total of at least five symptoms altogether) such as insomnia or hypersomnia, feeling of worthlessness or excessive guilt, fatigue or loss of energy, diminished ability to think or concentrate, substantial change in appetite or weight, psychomotor agitation or retardation and recurrent thoughts of death or suicide 1 . Depression is a major cause of morbidity worldwide. The WHO ranks depression as the fourth leading cause of disability worldwide and by 2020, it will could be the second leading cause. Population studies have consistently shown major depression is about twice as common in women as in men, although the underlying cause and factor is unclear. 
Methods
This interventional study was carried out in the department of Physiology, BSMMU, Dhaka, between January to December 2014. Thirty female newly diagnosed Major Depressive Disorder patients aged 20 to 50 years constituted study group. Study protocol was approved by Institutional Review Board (IRB) of BSMMU, Shahabag, Dhaka. Patients were randomly selected from the OPD of Psychiatry department of BSMMU, Dhaka. Subjects with pregnancy and lactation and history of lung diseases, coronary heart disease, diabetes mellitus, neurological disorders, smokers were excluded from the study. After selection when they agree to participate, an informed written consent was taken from each subject. A detail personal, medical, family, socioeconomic, occupational and drug history were recorded in a preformed questionnaire and through physical examinations were done and were documented. For this, assessment of lung function FEF 25%-75% of all the subjects were recorded by a digital spirometer before and after three months of antidepressive medication. Data were expressed as mean SE (Standard Error). Paired sample't' test was done to compare between the groups by using SPSS (Windows version 16). In the interpretation of results, p value 0.05 was accepted as level of significance.
Result
The Age, BMI & Blood pressure of the study group is shown in Table I . (Table II) . 
Discussion
The present study has been undertaken to observe pulmonary functions in 30 female MDD patients before and after three months of antidepressive medication. Pulmonary functions were assessed by measuring FEF 25%-75% with a portable micro spirometer. Different researchers found that pulmonary functions are significantly reduced in patients with depressive illness especially in major depressive disorder patients. These results suggest, FEF 25%-75% may be reduced in MDD patients. The apparent effect of depression on poor lung function in MDD patients may be explained by the reduced psychomotor activity along with poor respiratory muscle strength in depressive illness 7 . These 30 MDD patients who continued with antidepressive medication then again observed after three months and found that no significant improvements of lung function. So there is no role of antidepressive medication in improvement of depressed lung function in major depressive disorder.
Conclusion
From this study it may be concluded that antidepressive medication apparently did not have any effect on lung function.
